MARKET

AWH

AWH

Aspira Women`s Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.93
-0.13
-1.84%
Opening 13:47 02/26 EST
OPEN
7.08
PREV CLOSE
7.06
HIGH
7.47
LOW
6.80
VOLUME
217.59K
TURNOVER
--
52 WEEK HIGH
10.54
52 WEEK LOW
0.5310
MARKET CAP
773.12M
P/E (TTM)
-45.1466
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
BRIEF-Aspira Women’S Health Inc Appoints Nicole Sandford To Its Board Of Directors
reuters.com · 4d ago
Aspira Women’s Health Inc. Appoints Nicole Sandford to its Board of Directors
AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors. “I am very pleased to warmly welcome ...
GlobeNewswire · 4d ago
Aspira Women's Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month
February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women's Health Inc. (Nasdaq: AWH), a bioanaly...
GlobeNewswire · 02/17 13:00
Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
AUSTIN, Texas, Feb 12, 2021 (GLOBE NEWSWIRE via COMTEX) -- AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a...
GlobeNewswire · 02/12 21:18
Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX(TM) Clinical Report
AUSTIN, Texas, Feb 10, 2021 (GLOBE NEWSWIRE via COMTEX) -- AUSTIN, Texas, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a...
GlobeNewswire · 02/10 22:38
BRIEF-Aspira Women’s Health Inc Announces Pricing Of $45 Million Public Offering Of Common Stock
reuters.com · 02/04 14:27
Aspira Womens Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock
AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public ...
GlobeNewswire · 02/04 14:25
Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock
Aspira Women's Health Inc. (Nasdaq: AWH) ("Aspira"), a bio-analytical based women's health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 6,000,000 shares of its common stock ...
GlobeNewswire · 02/04 14:24
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AWH. Analyze the recent business situations of Aspira Women`s Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AWH stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 103
Institutional Holdings: 30.92M
% Owned: 27.72%
Shares Outstanding: 111.56M
TypeInstitutionsShares
Increased
38
1.31M
New
20
503.54K
Decreased
14
2.49M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.27%
Pharmaceuticals & Medical Research
-0.48%
Key Executives
Chairman/Independent Director
James LaFrance
President/Chief Executive Officer/Director
Valerie Palmieri
Chief Financial Officer
Robert Beechey
Independent Director
Sandra Brooks
Independent Director
Nancy Cocozza
Independent Director
Veronica Jordan
Independent Director
Nicole Sandford
Independent Director
David Schreiber
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
05/22/2017
Dividend USD 0
07/07/2017
05/22/2017
Special Dividend USD 5
07/07/2017
About AWH
Aspira Women’s Health Inc., formerly Vermillion, Inc., is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. The Company sells OVA1, Overa and OVA1PLUS risk of malignancy tests for ovarian cancer. The Company also sells a product for genetic testing for specific women’s health diseases, called ASPiRA GenetiX, with a core focus on ovarian cancer. OVA1 is a blood test designed to, in addition to a physician’s clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor before planned surgery. The Overa is a second-generation biomarker panel intended to maintain its product’s sensitivity while improving specificity. OVA1PLUS is a service offering combining its OVA1 and Overa products, designed to enhance accuracy and reduce false elevations in the intermediate-risk area.

Webull offers kinds of Aspira Women's Health Inc stock information, including NASDAQ:AWH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AWH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AWH stock methods without spending real money on the virtual paper trading platform.